Immunol Cell Biol
- JORDAN MA, Gresle MM, Gemiarto AT, Stanley D, et al
Transcriptional network analysis of peripheral blood leukocyte subsets in
multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated
gene network in myeloid cells.
Immunol Cell Biol. 2024 Jun 14. doi: 10.1111/imcb.12793.
J Neurol
- SIMANI L, Molaeipour L, Kian S, Leavitt VM, et al
Correlation between cognitive changes and neuroradiological changes over time in
multiple sclerosis: a systematic review and meta-analysis.
J Neurol. 2024 Jun 18. doi: 10.1007/s00415-024-12517.
Lancet Neurol
- FILIPPI M, Margoni M, Rocca MA
Multiple sclerosis diagnosis: a biologically driven perspective.
Lancet Neurol. 2024;23:668-669.
Mult Scler
- CONTE WL
Addressing LGBTQ+ health equity and disparities in multiple sclerosis: A call for
research and action.
Mult Scler. 2024 Jun 19:13524585241263281. doi: 10.1177/13524585241263281.
- MORROW SA, Hancock L
Monitoring cognitive functioning in multiple sclerosis will trigger anxiety in
patients: Commentary.
Mult Scler. 2024 Jun 16:13524585241261200. doi: 10.1177/13524585241261200.
- BALSHI A, Manning N, Dempsey J, Kumbar S, et al
Altered lymphocyte profiles and herpes zoster infections in patients with
multiple sclerosis on natalizumab.
Mult Scler. 2024 Jun 16:13524585241260537. doi: 10.1177/13524585241260537.
- KOLSCHE T, Willison AG, Meuth SG, Pawlitzki M, et al
Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple
sclerosis.
Mult Scler. 2024 Jun 15:13524585241260564. doi: 10.1177/13524585241260564.
Neurology
- CICCARELLI O, Barkhof F, Calabrese M, De Stefano N, et al
Using the Progression Independent of Relapse Activity Framework to Unveil the
Pathobiological Foundations of Multiple Sclerosis.
Neurology. 2024;103:e209444.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016